25th Jun 2025 Plain language summary: ECHELON-3 study results on using brentuximab vedotin combination therapy for diffuse large B-cell lymphoma patients
25th Jun 2025 Plain language summary: effectiveness and safety of larotrectinib in lung cancer patients with TRK fusion mutations – results from two trials
11th Jun 2025 Plain language summary: Examining how loncastuximab tesirine performs after CAR T-cell treatment for diffuse large B-cell lymphoma in everyday practice
11th Jun 2025 Real-world results of sequential loncastuximab and CAR T-cell therapy in large B-cell lymphoma: plain language summary
